logo

TEVA

Teva Pharmaceutical·NYSE
--
--(--)
--
--(--)

TEVA fundamentals

Teva Pharmaceutical (TEVA) released its earnings on Jan 28, 2026: revenue was 4.71B (YoY +11.37%), beat estimates; EPS was 0.96 (YoY +35.21%), beat estimates.
Revenue / YoY
4.71B
+11.37%
EPS / YoY
0.96
+35.21%
Report date
Jan 28, 2026
TEVA Earnings Call Summary for Q4,2025
  • Innovative Portfolio Dominance: AUSTEDO, UZEDY, and AJOVY drove 35% YoY growth, with AUSTEDO on track for $2.4-$2.55 billion in 2026.
  • Pipeline Acceleration: 7 key milestones in 2026, including duvakitug maintenance data, olanzapine LAI approval, and anti-IL-15 vitiligo results.
  • Financial Strength: 2025 free cash flow of $1.9 billion, with 2026 guidance of $2-$2.4 billion, supported by 6% CAGR and 30% operating margin target.
  • Biosimilars Expansion: 10 launched biosimilars, 6 more by 2027, and 10+ pipeline assets targeting $10 billion peak sales.
EPS
Revenue

Revenue & Expenses

TEVA has released its 2025 Q4 earnings report, with revenue of 4.71B, reflecting a YoY change of 11.40%, and net profit of 481.00M, showing a YoY change of 274.91%. The Sankey diagram below clearly presents TEVA's revenue sources and cost distribution.

Key Indicators

Teva Pharmaceutical (TEVA) key financial stats and ratios, covering profitability, financial health, and leverage.
Teva Pharmaceutical (TEVA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Teva Pharmaceutical (TEVA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Teva Pharmaceutical (TEVA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Teva Pharmaceutical (TEVA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Teva Pharmaceutical (TEVA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield